Literature DB >> 15565448

Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid.

Alice Y K Chan1, Edmund K Li, L S Tam, Gregory Cheng, Paul C L Choi.   

Abstract

We describe a middle-aged Chinese systemic lupus erythematosus (SLE) patient developing steroid refractory and transfusion dependent red cell aplasia. Oral danazol 200 mg twice per day was started together with low-dose prednisolone therapy. There was no further recurrence of anemia 1 month after this combined therapy.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15565448     DOI： 10.1007/s00296-004-0521-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  12 in total

1.  Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A.

Authors:  C Duarte-Salazar; J Cazarín-Barrientos; M V Goycochea-Robles; J Collazo-Jaloma; R Burgos-Vargas
Journal:  Rheumatology (Oxford)       Date:  2000-10       Impact factor: 7.580

2.  Efficacy of danazol in pure red cell aplasia.

Authors:  S M Lippman; B G Durie; H S Garewal; G Giordano; B R Greenberg
Journal:  Am J Hematol       Date:  1986-12       Impact factor: 10.047

3.  Pure red cell aplasia: lymphocyte inhibition of erythropoiesis.

Authors:  J L Abkowitz; M E Kadin; J S Powell; J W Adamson
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

4.  High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia.

Authors:  A Winkler; R W Jackson; D S Kay; E Mitchell; S Carmignani; G C Sharp
Journal:  Arthritis Rheum       Date:  1988-05

5.  Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW F1 hybrid mice.

Authors:  J P Michalski; C C McCombs; J R Roubinian; N Talal
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

6.  Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients.

Authors:  D A Clark; E N Dessypris; S B Krantz
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

7.  Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin.

Authors:  G D Linardaki; K A Boki; A Fertakis; A G Tzioufas
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

8.  Androgenic hormones modulate autoantibody responses and improve survival in murine lupus.

Authors:  J R Roubinian; R Papoian; N Talal
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

9.  Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin.

Authors:  Y Ilan; Y Naparstek
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

10.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307
View more
  2 in total

1.  A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.

Authors:  Haruko Ideguchi; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

Review 2.  Acquired pure red cell aplasia in a patient with ankylosing spondylitis- a case report and literature review.

Authors:  Xianfang Shao; Wei Wei; Yangzhi Zhao; Xinyue Liang; Qiuju Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.